Physician

Vijayendra K Verma, MD

According to 2025 Medicare claims, Vijayendra Verma, MD (NPI: 1275585846) practices interventional cardiology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is CARDIOVASCULAR ASSOCIATES OF THE DELAWARE VALLEY,P A (NPI: 1366495632; TIN: 223321233) and primary practice location at 08035-1994.

Verma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 961 traditional Medicare patients, billed 3,120 HCPCS/CPT codes, and received $889,561 in Medicare payments. The top billing code was 93970 (Ultrasound study of arm or leg veins with compression and maneuvers). Part D data shows 1,977 prescription claims across 364 beneficiaries totaling $247,644 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 18 claims. Open Payments data shows 65 records totaling $20,254. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $338,332 to $889,561. Similarly, Part D prescription costs have moved sharply higher in recent years, from $98,325 to $247,644. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,249	3,033	$338,332
2016	1,241	2,664	$328,937
2017	1,367	3,072	$321,949
2018	1,451	3,285	$383,050
2019	1,148	2,815	$375,180
2020	1,066	2,551	$374,141
2021	1,228	2,908	$418,055
2022	1,045	2,668	$798,911
2023	868	2,973	$905,305
2024	961	3,120	$889,561

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	262	1,592	$98,325
2016	260	1,653	$120,536
2017	276	1,468	$135,591
2018	274	1,536	$129,251
2019	274	1,598	$143,888
2020	283	1,680	$144,077
2021	277	1,633	$161,186
2022	278	1,666	$146,239
2023	359	1,835	$304,826
2024	364	1,977	$247,644

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	18	$36,266
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93970	Ultrasound study of arm or leg veins with compression and maneuvers	132	134	$168
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	314	451	$103
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	191	244	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	212	327	$12
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	208	270	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	98	6,965	$131,694
Xarelto	Rivaroxaban	28	1,620	$28,477
Entresto	Sacubitril/Valsartan	14	1,080	$22,917
Brilinta	Ticagrelor	18	1,380	$19,240
Metoprolol Succinate	Metoprolol Succinate	276	23,865	$4,956

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$1,632	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$18,622	CSL Behring
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vijayendra K. Verma, MD?

Tedicare shows public-source Medicare data for Vijayendra K. Verma, MD (NPI 1275585846), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vijayendra K. Verma, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vijayendra K. Verma, MD?

Vijayendra K. Verma, MD is linked to CARDIOVASCULAR ASSOCIATES OF THE DELAWARE VALLEY,P A (billing NPI 1366495632) in the available physician profile data.

Does Vijayendra K. Verma, MD have Open Payments data?

Vijayendra K. Verma, MD has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.